Clinical trial · Observational
Analysis and Evaluation of Smoking Treatment With Cytisine
Analysis and Evaluation of Smoking Treatment With Cytisine: Retrospective Observational Study
NCT06439303CI-TRIAL-00077648unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The lack of clinical studies on the use of Cytisine in the treatment of the cessation of smoking, the need to find effective therapeutic alternatives and the opportunity to reduce costs related to the complications of cigarette smoking, represent the main reasons that led to the design of this study.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Moderate or Severe Tobacco Use Disorder | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Cytisine 1,5 mg | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Patients with moderate or severe tobacco use disorder.
- description
- Patients hospitalized at the IRE anti-smoking center, National Cancer Institute "Regina Elena", suffering from moderate or severe tobacco use disorder, who are prescribed pharmacological therapy with Cytisine 1.5 mg.
- interventionNames
- Drug: Cytisine 1,5 mg
Primary outcomes (1)
- measure
- Therapeutic adherence
- timeFrame
- 3 months
- description
- Evaluation of adherence to the prescribed drug therapy i.e. Cytisine 1.5 mg
Secondary outcomes (4)
- measure
- Evaluation of the effectiveness of the therapy.
- timeFrame
- 3 months
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * patients aged \> 18 years; * patients suffering from moderate or severe tobacco use disorder; * prescription of pharmacological therapy with Cytisine; * patients returned to the 1st check-up on schedule; Exclusion Criteria: * Patients with contraindications to taking Cytisine and partial receptor agonists nicotinic cholinergics; * Patients undergoing pharmacological or physical treatment for neoplastic pathology; * Pregnant or breastfeeding women; * Patients for whom specific information for objective assessments is not available;
References
Publications (0)
Data not yet available
No reference posted for this study.